Why We Started This Company

Revenue cycle management is a $20 billion industry that runs on unverifiable trust. A vendor reports a 96% clean-claim rate, 92% first-pass resolution, 34-day average AR — and the practice can't audit a single number. They arrive in a summary the vendor writes about its own performance, with no independent source of truth and no consequence if the numbers run generous. That gap between what's reported and what's real is exactly where lost revenue hides: denials never reworked, underpayments never caught, coding quietly downgraded. It's rarely dramatic — a percentage point here, a missed appeal there, aging AR that slips past a filing deadline. Across a year, it's the difference between a healthy practice and a struggling one.

We saw this from two sides. As technologists, we recognized that RCM data infrastructure is built to produce reports, not accountability — designed to summarize, not to prove. And in talking to independent practices, we saw the cost up close: owners and billing managers who suspected they were leaving money on the table but had no way to know for sure. We started NuGenera Health to close that gap — to replace unverifiable trust with numbers a practice can actually check.

As a new company, we're offering preferred pricing to a small group of early partners in exchange for something valuable to us: permission to publish their 90-day performance baselines. You get better economics and a partner deeply invested in your results; we get real, measurable before-and-after data we can stand behind.

There's no fabricated proof in this arrangement — just measurable improvement within 90 days, documented and, with your consent, shared. It's an honest trade, and it's how we'd rather earn credibility than by borrowing logos we have no right to.